The Supreme Court is allowing the…
The Supreme Court is allowing the Trump administration to axe [...]
Arena BioWorks has laid off 30% of…
Arena BioWorks has laid off 30% of its workers 19 [...]
Lighthouse Pharmaceuticals’ plan…
Lighthouse Pharmaceuticals’ plan to become a beacon of hope for [...]
The Cleveland Clinic’s Nathan…
The Cleveland Clinic’s Nathan Pennell, M.D., Ph.D., is switching to [...]
The FDA’s recent rebuff of…
The FDA’s recent rebuff of Replimune’s melanoma candidate has rippled [...]
The FDA has accepted Stealth…
The FDA has accepted Stealth BioTherapeutics’ third new drug application [...]
Gilead has become the latest…
Gilead has become the latest pharma to strengthen its in [...]
Dynavax’s lofty ambition to…
Dynavax’s lofty ambition to snatch Shingrix’s crown got off to [...]
The FDA has freed Rocket…
The FDA has freed Rocket Pharmaceuticals from a clinical hold, [...]
Xoma Royalty is ravenous for…
Xoma Royalty is ravenous for biotechs, and the Bay Area [...]